These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 27630251

  • 1. Candida species diversity and antifungal susceptibility patterns in oral samples of HIV/AIDS patients in Baja California, Mexico.
    Clark-Ordóñez I, Callejas-Negrete OA, Aréchiga-Carvajal ET, Mouriño-Pérez RR.
    Med Mycol; 2017 Apr 01; 55(3):285-294. PubMed ID: 27630251
    [Abstract] [Full Text] [Related]

  • 2. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G.
    Rev Iberoam Micol; 2005 Jun 01; 22(2):83-92. PubMed ID: 16107165
    [Abstract] [Full Text] [Related]

  • 3. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 01; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 4. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY, Chen WY, Li X, Li HB, Li HQ, Wang L, He L, Yang XP, Wang XC, Huang YL, Yao YG.
    BMC Infect Dis; 2013 Jan 28; 13():46. PubMed ID: 23356471
    [Abstract] [Full Text] [Related]

  • 5. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
    Ambe NF, Longdoh NA, Tebid P, Bobga TP, Nkfusai CN, Ngwa SB, Nsai FS, Cumber SN.
    Pan Afr Med J; 2020 Jan 28; 36():23. PubMed ID: 32774600
    [Abstract] [Full Text] [Related]

  • 6. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors.
    Paula SB, Morey AT, Santos JP, Santos PM, Gameiro DG, Kerbauy G, Sena EM, Ueda LT, Carneiro M, Pinge-Filho P, Yamauchi LM, Yamada-Ogatta SF.
    J Infect Dev Ctries; 2015 Dec 30; 9(12):1350-9. PubMed ID: 26719941
    [Abstract] [Full Text] [Related]

  • 7. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R.
    J Oral Pathol Med; 2014 Oct 30; 43(9):696-703. PubMed ID: 24931443
    [Abstract] [Full Text] [Related]

  • 8. Oral Candida carriage and immune status in Thai human immunodeficiency virus-infected individuals.
    Thanyasrisung P, Kesakomol P, Pipattanagovit P, Youngnak-Piboonratanakit P, Pitiphat W, Matangkasombut O.
    J Med Microbiol; 2014 May 30; 63(Pt 5):753-759. PubMed ID: 24591706
    [Abstract] [Full Text] [Related]

  • 9. Antifungal susceptibility of oral isolates of Candida species from chronic kidney disease patients on chronic dialysis.
    de la Rosa-García E, Olalde-Hernández MJ, Irigoyen-Camacho ME, Mondragón-Padilla A, Mendoza-Juache A, Sánchez-Vargas LO.
    J Mycol Med; 2020 Sep 30; 30(3):101009. PubMed ID: 32620497
    [Abstract] [Full Text] [Related]

  • 10. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
    Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Magaró HM.
    Mycoses; 2009 Jan 30; 52(1):53-9. PubMed ID: 18498298
    [Abstract] [Full Text] [Related]

  • 11. Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
    Treviño-Rangel Rde J, Garza-González E, González JG, Bocanegra-García V, Llaca JM, González GM.
    Med Mycol; 2012 Oct 30; 50(7):781-4. PubMed ID: 22493945
    [Abstract] [Full Text] [Related]

  • 12. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN, Lin CC, Lai CH, Yang YL, Chen HT, Weng HC, Hsieh LY, Kuo YC, Lauderdale TL, Tseng FC, Lin HH, Lo HJ.
    J Microbiol Immunol Infect; 2013 Apr 30; 46(2):129-35. PubMed ID: 22921200
    [Abstract] [Full Text] [Related]

  • 13. Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count.
    Erköse G, Erturan Z.
    Mycoses; 2007 Nov 30; 50(6):485-90. PubMed ID: 17944711
    [Abstract] [Full Text] [Related]

  • 14. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization.
    Delgado AC, de Jesus Pedro R, Aoki FH, Resende MR, Trabasso P, Colombo AL, de Oliveira MS, Mikami Y, Moretti ML.
    Clin Microbiol Infect; 2009 Apr 30; 15(4):364-71. PubMed ID: 19431223
    [Abstract] [Full Text] [Related]

  • 15. Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon.
    Dos Santos Abrantes PM, McArthur CP, Africa CW.
    Diagn Microbiol Infect Dis; 2014 Jun 30; 79(2):222-7. PubMed ID: 24726686
    [Abstract] [Full Text] [Related]

  • 16. Oropharyngeal carriage of Candida species in HIV-infected patients in India.
    Gugnani HC, Becker K, Fegeler W, Basu S, Chattopadhya D, Baveja U, Satyanarayana S, Kalghatgi T, Murlidhar A.
    Mycoses; 2003 Sep 30; 46(8):299-306. PubMed ID: 12950898
    [Abstract] [Full Text] [Related]

  • 17. Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia.
    Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, Belyhun Y, Biadglegne F, Hurissa Z, Moges F, Isogai E.
    BMC Infect Dis; 2013 Feb 12; 13():82. PubMed ID: 23398783
    [Abstract] [Full Text] [Related]

  • 18. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 12; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 19. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study.
    Goulart LS, Souza WWR, Vieira CA, Lima JS, Olinda RA, Araújo C.
    Einstein (Sao Paulo); 2018 Aug 06; 16(3):eAO4224. PubMed ID: 30088546
    [Abstract] [Full Text] [Related]

  • 20. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
    Costa CR, de Lemos JA, Passos XS, de Araújo CR, Cohen AJ, Souza LK, Silva Mdo R.
    Mycopathologia; 2006 Jul 06; 162(1):45-50. PubMed ID: 16830191
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.